alexa Abstract | The possible implication of clusterin-dependent serum cholesterol traffick-ing in Alzheimer?s disease

Current Neurobiology
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)


Hypercholesterolemia is known as a major risk of atherosclerosis. However, recent studies revealed that elevated level of LDL (“known as bad cholesterol”) predisposes also to dementia, stroke and neuropathies including Alz-heimer’s disease (AD). The relationship between the blood cholesterol level and AD has not been completely ex-plained, however, the clusterin/ApoJ role seems to be pivotal. Clusterin is a glycoprotein expressed by various cell types. Moreover, Clu/ApoJ is secreted into body fluids and its expression is stimulated in response to raised sterol levels. In blood, Clu/ApoJ interacts with other lipoproteins, plasma proteins or lipids, including cholesterol, and is also capable to translocate through the blood-brain barrier. Additionally, the high blood plasma levels of choles-terol promote formation of plasma membrane lipid rafts, enriched in β-secretase enzyme. Consequently, the ab-normal amyloid β precursor protein (AβPP) cleavage may occur and neurotoxic amyloid β is produced. Thus, the intensity of amyloid β processing is apparently related to cholesterol concentration, and could be limited by cho-lesterol-depleting agents such as statins. Interestingly, Clu/ApoJ is not merely transported from blood plasma into brain, but at the same time it is secreted by astrocytes to extracellular fluid. Clu/ApoJ interacts with Aβ1-40 and is accumulated in peptide plaques. To maintain Aβ in soluble form, the extracellular Clu/ApoJ is simultaneously complexed with Aβ. Finally, intracellular variant of clusterin is admitted to mediate the activation of Ca2+-permeable ion channels, which initiate Aβ-induced neuronal cell apoptosis. Taken together, we hypothesize, that Clu/ApoJ plays an important role in cholesterol-dependent AD pathogenesis and should be seriously considered as a component in AD pathology.

To read the full article Peer-reviewed Article PDF image

Author(s): Beata Pajak Arkadiusz Orzechowski Barbara Gajkowska


Hypercholesterolemia, atherosclerosis, cholesterol, neuropathies, Alzheimer’s disease, glycoprotein

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version